Notice: This company has been marked as potentially delisted and may not be actively trading. Reliv' International (RELV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends RELV vs. SLGL, NLSP, NRSN, SNSE, TLPH, EGRX, CSCI, APLM, IPA, and INDPShould you be buying Reliv' International stock or one of its competitors? The main competitors of Reliv' International include Sol-Gel Technologies (SLGL), NLS Pharmaceutics (NLSP), NeuroSense Therapeutics (NRSN), Sensei Biotherapeutics (SNSE), Talphera (TLPH), Eagle Pharmaceuticals (EGRX), COSCIENS Biopharma (CSCI), Apollomics (APLM), ImmunoPrecise Antibodies (IPA), and Indaptus Therapeutics (INDP). Reliv' International vs. Sol-Gel Technologies NLS Pharmaceutics NeuroSense Therapeutics Sensei Biotherapeutics Talphera Eagle Pharmaceuticals COSCIENS Biopharma Apollomics ImmunoPrecise Antibodies Indaptus Therapeutics Reliv' International (NASDAQ:RELV) and Sol-Gel Technologies (NASDAQ:SLGL) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, community ranking, analyst recommendations, valuation and risk. Which has better earnings & valuation, RELV or SLGL? Reliv' International has higher revenue and earnings than Sol-Gel Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReliv' International$35.06M0.09-$440KN/AN/ASol-Gel Technologies$1.55M8.54-$27.24M-$0.34-1.40 Do analysts rate RELV or SLGL? Sol-Gel Technologies has a consensus price target of $5.00, indicating a potential upside of 952.41%. Given Sol-Gel Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Sol-Gel Technologies is more favorable than Reliv' International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Reliv' International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is RELV or SLGL more profitable? Reliv' International has a net margin of -0.61% compared to Sol-Gel Technologies' net margin of -81.75%. Reliv' International's return on equity of -1.89% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Reliv' International-0.61% -1.89% -1.31% Sol-Gel Technologies -81.75%-27.17%-22.49% Does the MarketBeat Community believe in RELV or SLGL? Sol-Gel Technologies received 45 more outperform votes than Reliv' International when rated by MarketBeat users. However, 70.27% of users gave Reliv' International an outperform vote while only 63.40% of users gave Sol-Gel Technologies an outperform vote. CompanyUnderperformOutperformReliv' InternationalOutperform Votes10470.27% Underperform Votes4429.73% Sol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% Does the media prefer RELV or SLGL? In the previous week, Sol-Gel Technologies had 9 more articles in the media than Reliv' International. MarketBeat recorded 9 mentions for Sol-Gel Technologies and 0 mentions for Reliv' International. Sol-Gel Technologies' average media sentiment score of 0.46 beat Reliv' International's score of 0.00 indicating that Sol-Gel Technologies is being referred to more favorably in the news media. Company Overall Sentiment Reliv' International Neutral Sol-Gel Technologies Neutral Which has more volatility & risk, RELV or SLGL? Reliv' International has a beta of -0.1, meaning that its stock price is 110% less volatile than the S&P 500. Comparatively, Sol-Gel Technologies has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Do insiders and institutionals have more ownership in RELV or SLGL? 8.0% of Reliv' International shares are owned by institutional investors. Comparatively, 26.2% of Sol-Gel Technologies shares are owned by institutional investors. 31.2% of Reliv' International shares are owned by insiders. Comparatively, 66.5% of Sol-Gel Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummarySol-Gel Technologies beats Reliv' International on 11 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Reliv' International News Delivered to You Automatically Sign up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RELV vs. The Competition Export to ExcelMetricReliv' InternationalPharmaceutical Preparations IndustryStaples SectorNASDAQ ExchangeMarket Cap$3.32M$6.58B$14.60B$8.84BDividend YieldN/A8.11%2.65%4.07%P/E Ratio-17.2710.9323.3317.61Price / Sales0.09363.854.4386.52Price / Cash44.5352.5920.7736.27Price / Book0.3010.176.166.36Net Income-$440,000.00$153.36M$578.24M$226.00M Reliv' International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RELVReliv' InternationalN/A$1.90-40.6%N/AN/A$3.32M$35.06M-17.2791SLGLSol-Gel Technologies3.6414 of 5 stars$0.48+6.7%$5.00+952.4%-68.5%$13.24M$1.55M-1.4050News CoverageGap DownNLSPNLS Pharmaceutics1.2366 of 5 stars$3.37+2.4%N/A+623.1%$12.85MN/A0.006NRSNNeuroSense Therapeutics0.2267 of 5 stars$0.91-8.1%N/A+92.7%$12.47MN/A-1.0718Upcoming EarningsSNSESensei Biotherapeutics4.8087 of 5 stars$0.48-2.0%$4.33+795.3%-20.0%$12.17MN/A-0.4140News CoverageTLPHTalphera2.1466 of 5 stars$0.70-1.4%$4.50+543.6%N/A$12.03M$281,000.00-1.0119Gap UpEGRXEagle Pharmaceuticals1.1176 of 5 stars$0.90+38.5%N/A-92.5%$11.69M$316.61M0.00134Analyst ForecastGap UpCSCICOSCIENS BiopharmaN/A$2.99+0.3%N/AN/A$11.24M$4.50M-0.25N/AGap DownHigh Trading VolumeAPLMApollomics2.7483 of 5 stars$0.10-33.1%$2.00+1,880.2%-81.3%$10.98M$1.22M0.0045Stock SplitNews CoverageGap DownIPAImmunoPrecise Antibodies2.0405 of 5 stars$0.37-5.1%$6.00+1,522.1%-72.2%$10.66M$18.16M-0.4780INDPIndaptus Therapeutics2.728 of 5 stars$1.05-1.9%$8.50+713.4%-48.7%$10.66MN/A-0.616 Related Companies and Tools Related Companies SLGL Competitors NLSP Competitors NRSN Competitors SNSE Competitors TLPH Competitors EGRX Competitors CSCI Competitors APLM Competitors IPA Competitors INDP Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RELV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reliv' International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reliv' International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
